Consumer products company Colgate-Palmolive (NYSE: CL) reported Q3 2026 results topping the market’s revenue expectations, with sales up 4.6% year on year to $5.37 billion. Its non-GAAP profit of $0.97 per share was 4.8% above analysts’ consensus estimates.

Is now the time to buy CL? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Colgate-Palmolive’s third quarter was marked by broad-based organic sales growth and a positive market reaction, as management attributed the momentum to strong emerging market demand and continued progress in its premium product strategies. CEO Noel Wallace emphasized that new product launches and increased advertising spend, especially in categories like oral care and pet nutrition, contributed to solid volume gains. Wallace noted, “Our strong on-the-ground execution, coupled with our continued investment in our AI capabilities, helped drive our performance.” Strength in India, Brazil, and China supported emerging market growth, while improved market share in U.S. toothpaste was highlighted as an early sign of turnaround.

Looking ahead, Colgate-Palmolive’s management expects persistent cost inflation and logistics challenges to continue into next year, but remains focused on offsetting these pressures through pricing, productivity initiatives, and premium innovation. Wallace stated that the company will “increase both the pace and impact of innovation, with a pipeline focused on premium opportunities that can grow at scale.” Investment in AI-driven tools for demand generation and revenue management is expected to enhance marketing effectiveness, while ongoing efforts to optimize the U.S. business and scale global premium offerings are seen as central to future performance.

Key insights from management’s remarks

Management pointed to premium product innovation, regional execution, and productivity gains as the main drivers of third quarter results, while also outlining the company’s approach to address ongoing cost inflation and margin preservation.

• Premium innovation momentum: New product launches and portfolio premiumization fueled growth, particularly in oral care and Hill's pet nutrition. Management highlighted success with premium toothpaste relaunches and the expansion of therapeutic and wet pet food segments, which outpaced the overall category.
• Emerging market strength: Sales growth was led by India, Brazil, and China, with India and Brazil delivering double-digit gains. Regionally tailored strategies and increased advertising investment delivered market share gains despite volatile consumer backdrops.
• Productivity and cost control: The Strategic Growth and Productivity Program (SGPP) and funding-the-growth initiatives offset material and logistics inflation. CFO Stan Sutula pointed to 290 basis points in productivity savings as key to maintaining gross margins, despite ongoing pressure from commodities and freight costs.
• AI and digital transformation: The rollout of PromoAI and other proprietary AI tools accelerated product ideation and optimized promotional spending. Management reported that AI-driven analytics enabled faster innovation cycles and more precise marketing, especially in digital and emerging commerce channels.
• U.S. business turnaround efforts: While the U.S. remains a work in progress, management reported early signs of improvement in toothpaste market share and outlined plans to strengthen core brands, accelerate premium innovation, and restructure go-to-market strategies to win in priority channels, including digital and social commerce.

Drivers of future performance

Colgate-Palmolive expects premium innovation, productivity gains, and AI-driven marketing to support growth, while remaining cautious about persistent cost inflation and volatile global demand.

• Ongoing cost headwinds: Management expects elevated commodity and logistics costs to persist into next year, with Q4 flagged as the peak for inflationary pressures. CFO Stan Sutula emphasized that productivity initiatives and revenue growth management are critical to offsetting these headwinds, but noted that volatility in raw materials and freight will require ongoing vigilance.
• Scaling premium and digital: The company aims to accelerate the pace of premium product launches globally, including in oral care and pet nutrition, supported by AI-enabled marketing and expansion into high-growth digital channels. CEO Noel Wallace believes these efforts will enable Colgate-Palmolive to capture share in faster-growing segments and strengthen brand loyalty.
• Focus on U.S. recovery: Management described the U.S. as a key area of focus, targeting a long-term reset with increased advertising, premium innovation, and structural changes to commercial teams. Progress in scaling premium bundles and optimizing data-driven marketing is expected to be gradual, with the goal of returning to sustainable organic growth and market share gains.

Catalysts in upcoming quarters

Going forward, the StockStory team will be watching (1) the effectiveness of premium product launches and the scaling of AI-powered marketing, (2) the ability to maintain gross margins as cost inflation persists, and (3) continued signs of U.S. market share recovery, especially in oral care. The pace of innovation and execution on revenue growth management strategies will be key markers of sustained performance.

Colgate-Palmolive currently trades at $95.61, up from $93.16 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

High quality stocks for all market conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.